#MarketAlert | Many stocks have recovered from over 10% to as much as 24% from March lows
Take a quick look at the top gainers from the recent market slump👇#Nifty #StockMarket #StockMarketIndia pic.twitter.com/uD5nGOB0A1
— ET NOW (@ETNOWlive) March 24, 2025
U.S. stock futures jumped on Monday as investors welcomed reports that the next wave of President Trump’s tariffs will be more targeted than previously threatened. S&P 500 futures rose 0.9%, building on the gains of the week prior. Dow Jones Industrial Average futures advanced 0.7%, while contracts on the tech-heavy Nasdaq 100 led the gains, up 1.1%.
Stock Market: Investors gain Rs 22.12 lakh crore in 5 days as Sensex zooms 3076 points or 4%#StockMarket https://t.co/q4E0QUcjZd
— ET NOW (@ETNOWlive) March 22, 2025
Investors are optimistic that the tariffs, set to be announced on April 2, will be narrower in scope than initially feared. This has provided some relief from concerns that an escalating trade war could increase inflation and further slow economic growth. The yield on the 10-year Treasury note dipped to 4.29% as worries about the tariffs’ impact on growth and global trade eased, and risk appetite sharpened.
New 52-week lows among S&P 500 members didn’t aggressively spike in recent correction … not quite as close to fall 2023 and nowhere near prior bear markets pic.twitter.com/SZQyxvdW4l
— Liz Ann Sonders (@LizAnnSonders) March 24, 2025
Looking ahead, the market is awaiting key economic data this week, including the Federal Reserve’s preferred inflation gauge, the Personal Consumption Expenditures (PCE) Index, due Friday.
Stock futures rise on targeted tariffs
Additionally, results from the University of Michigan’s consumer confidence survey and updates to the Purchasing Managers’ Indexes for the manufacturing and services sectors are expected to provide further insights into the economy’s health.
On the corporate earnings front, quarterly results from Lululemon, Gamestop, and Dollar Tree are the highlights in an otherwise quiet week of releases. In other news, the troubled DNA testing company 23andMe has filed for bankruptcy, causing its shares to plummet over 40% before the bell. The move is intended to facilitate the search for a buyer for the $50 million genetic test provider.
Co-founder Anne Wojcicki has stepped down as CEO following a series of failed takeover bids. Investors are keeping a close eye on these developments as the market navigates through a mix of economic indicators and corporate news. The outcomes of these events will likely set the tone for market sentiment in the coming weeks.
